Provided by Tiger Trade Technology Pte. Ltd.

JPMORGAN HEALTHCARE LEADERS ETF

63.36
+0.79391.27%
Volume:300
Turnover:19.01K
Market Cap:9.50M
PE:- -
High:63.36
Open:63.15
Low:63.15
Close:62.56
52wk High:64.69
52wk Low:50.34
Shares:150.00K
Float Shares:150.00K
Volume Ratio:0.73
T/O Rate:0.20%
Dividend:0.51
Dividend Rate:0.81%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Merck's Near-Term Catalysts Create Bull-Bear Debate, RBC Capital Markets Says

MT Newswires Live
·
Aug 21

Merck & Co Inc Stock (MRK) Moved Up by 3.41% on Aug 21: Facts Behind the Movement

TradingKey
·
Aug 21

Jabil Stock Leads 3 Undervalued Cash Flow Picks With AI Data Center Exposure

Simply Wall St.
·
Aug 21

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims

TIPRANKS
·
Aug 21

Johnson & Johnson Says Multiple Myeloma Treatment Approved by European Commission

MT Newswires Live
·
Aug 21

African Markets - Factors to Watch on Aug 21

Reuters
·
Aug 21

Moderna’s Personalized MRNA Shot Could Reshape the Fight Against Skin Cancer — but It May Also Be Overhyped

Dow Jones
·
Aug 21

Perrigo Co. PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 21

Does J&J’s MONARCH QUEST 3 Approval and MedTech Momentum Change The Bull Case For Johnson & Johnson (JNJ)?

Simply Wall St.
·
Aug 21

Thursday's Top 20 US Stock Transactions: Micron Rises 3.97% Following $10 Billion Research Lab Announcement

Deep News
·
Aug 21

Moderna is up 350% Since Our Recommendation. Here's What to Do Next.

Dow Jones
·
Aug 21

Sector Update: Healthcare Stocks Fall Thursday Afternoon

MT Newswires Live
·
Aug 21

Congo Set to Receive 70,000 Ervebo Vaccines to Contain Ebola Outbreak, WHO Says

Reuters
·
Aug 21

Gavi Announces $7 Mln Funding for Shipment of 70,000 Doses of Ervebo Vaccine to DRC

Reuters
·
Aug 21

Merck Stock (MRK) Is a Strong Buy Now as 3 Top Wall Street Analysts Hike Price Targets

TIPRANKS
·
Aug 21

AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study

TIPRANKS
·
Aug 21

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

TIPRANKS
·
Aug 21

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

TIPRANKS
·
Aug 21

Merck is Maintained at Buy by UBS

Dow Jones
·
Aug 21